SS
Sumita Singh
About Sumita Singh
Data last updated:
Sumita Singh is a Director at Mandore Pharma Private Limited (since 2019) and Director at Mandore Edutech Private Limited (since 2016). The companies operate in Pharma and Business Outsourcing. The 2 current companies with reported revenue have a combined latest revenue of ₹4.59 Cr; the largest is Mandore Pharma Private Limited at ₹4.16 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mandore Pharma Private Limited U24304UP2019PTC113820 | Director | 19 Feb 2019 | 2019 | ₹4.16 Cr (FY 2025) | Active |
| Mandore Edutech Private Limited U74999DL2016PTC300664 | Director | 31 May 2016 | 2016 | ₹43.5 Lakh (FY 2025) | Active |
Board colleagues of Sumita Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mahendri | 07061588 | Mandore Pharma Private Limited | Director |
| Sunil Panwar | 07061586 | Mandore Edutech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sumita Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sumita Singh
Sumita Singh currently holds 2 directorships: Mandore Pharma Private Limited (Director, since 19 Feb 2019, revenue ₹4.16 Cr (FY 2025)); Mandore Edutech Private Limited (Director, since 31 May 2016, revenue ₹43.5 Lakh (FY 2025)).
Sumita Singh was first appointed on 31 May 2016 as Director at Mandore Edutech Private Limited. The most recent appointment on record is 19 Feb 2019 at Mandore Pharma Private Limited.
The 2 current companies of Sumita Singh that report revenue have a combined latest revenue of ₹4.59 Cr: Mandore Pharma Private Limited ₹4.16 Cr (FY 2025); Mandore Edutech Private Limited ₹43.5 Lakh (FY 2025).
The current boards of Sumita Singh's companies include Mahendri (Mandore Pharma Private Limited), Sunil Panwar (Mandore Edutech Private Limited).